Skip to main content
Case studies

From investment to impact: building the largest and most versatile privately owned hospital group in Poland

Company
Scanmed
PE/VC investor
Abris Capital Partners
Investment period
2021 - 2024

1.75

Sales growth

5

EBITDA growth

Abris acquired Scanmed in 2021 with a plan to build a national healthcare champion. The key building blocks of the strategy were an ambitious buy-and-build programme combined with improving the quality of the services provided and increasing their variety and availability for patients.

Under Abris’s ownership, Scanmed completed four add-on acquisitions, expanded into new therapeutic areas, increased the scale of multi-profile hospitals and enhanced the quality of medical services. This enabled the company to develop effective model of cooperation between the NFZ, local communities and a privately owned operator in Poland’s healthcare sector.

The value creation strategy implemented during Abris’s three-year investment and the accompanying ESG initiatives positioned Scanmed as a leading provider of diversified range of high-quality inpatient healthcare services in Poland.

The company doubled its scale and achieved 5x EBITDA growth through improved operational efficiency and by combining organic growth with market consolidation. At the time of exit, Scanmed operated 40 facilities across the country, including seven hospitals and 20 medical centres, and employed over 1,300 physicians.

Scanmed was sold in 2024 to American Heart of Poland Group backed by Gruppo San Donato, the leading Italian hospital group.

Main PE/VC
funding objectives

  • Expansion into new regions of Poland and broadening the range of therapeutic areas through a buy-and-build programme
  • Investment in critical medical and infrastructure upgrades to reach the highest medical and operational standards
  • Identification and capture of synergies across business segments and medical units
  • Strengthening organizational capabilities with a focus on ESG transformation and service quality

What changed in the company after the PE/VC investment

  • Completed four add-on acquisitions: ARS Medical (2022), Med-Lux (2023), Centrum Rehabilitacji Chorzów and Vital Medic (2024). The transactions helped the group deliver above-market growth by increasing its footprint and number of facilities. Scanmed expanded into new regions of Poland and broadened the range of therapeutic areas, treating over 560,000 patients annually.
  • Deployed more than EUR 20m through an accelerated capex programme, upgrading priority infrastructure and medical equipment to achieve leading clinical and operational benchmarks.
  • Introduced new therapeutic areas and expanded multi-profile hospital capacity while unlocking synergies and fostering cooperation across the group’s medical units.
  • Professionalized the organization by building a strong leadership team, including the appointment of the CEO, CFO and COO with extensive experience in business transformation and execution of organic growth strategies, capable to deliver clear and ambitious goals.

ESG-related initiatives and accomplishments

  • Delivered ESG-focused transformation through infrastructure and medical equipment upgrades
  • Improved the availability of healthcare services for patients through increased efficiency of operations
  • Strengthened governance and procedures to best-in-class standards
  • Implemented energy efficiency measures, introduced a decarbonization action plan and secured a green energy supply for its facilities
  • Accelerated digitalization with enhanced cybersecurity, optimized management of medical records and streamlined back-office processes.

This has been a highly productive partnership between the management team and the fund during their three-year investment. Working as a group, we have focused hard on the quality of our facilities and services, strengthening our long-term relationships with local communities and creating a better working environment for medical personnel.

Andrzej Podlipski

CEO of Scanmed